Champions Oncology Inc (FRA:2I3)

Q4 2025 Champions Oncology Inc Earnings Call Transcript

Jul 23, 2025 / 08:30 PM GMT

Release Date Price: €6.55 (-3.68%)

Transcript 10-K8-K

Key Points

Positve

Champions Oncology Inc (CSBR) returned to profitability in fiscal 2025 after a challenging fiscal 2024.
The company achieved a record total revenue of $57 million, marking a 14% increase from the previous year.
Champions Oncology Inc (CSBR) successfully closed its inaugural data licensing deal, validating its data platform.
The launch of the radio pharmaceutical services platform is expected to drive high-margin business opportunities.
The company ended the year with $9.8 million in cash and remains debt-free, indicating strong financial health.

Negative

The fourth quarter revenue was weaker both sequentially and compared to the same quarter last year.
Gross margin for the fourth quarter declined to 41% from 48% in Q4 2024 due to lower revenue on a relatively unchanged cost base.
Operating expenses for the quarter rose by 7%, driven by increased sales and marketing costs.
The current market environment remains tight, with ongoing macroeconomic headwinds affecting biotech and pharma R&D budgets.
The data licensing business is still in its early stages, with some deals taking longer to materialize.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CSBR.OQ - Champions Oncology Inc
Q4 2025 Champions Oncology Inc Earnings Call
Jul 23, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the champions Oncology 4th quarter fiscal year 2025 earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press 0 on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to your host, Ronnie Morris, Chief Executive Officer. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
I'm Ronnie Morty of Champions oncology. Joining me today is David Miller

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.